Heptares Information

View Top Employees from Heptares

Heptares is a clinical-stage company creating transformative medicines targeting G protein-coupled receptors (GPCRs), a superfamily of receptors linked to a wide range of human diseases. We are an industry pioneer in GPCR structure-based drug design (SBDD) and have built a powerful and unique capability for discovering both small molecule and antibody medicines targeting GPCRs. Our SBDD platform enables us to unlock GPCRs that have strong clinical and biological validation, yet which have proven to be historically hard to drug. Our pharmaceutical partners include Allergan, Pfizer, Teva, AstraZeneca, MorphoSys and Kymab. Heptares is a wholly owned subsidiary of Sosei Group Corporation. To learn more about Heptares, please visit www.heptares.com.

Website	http://www.heptares.com
Revenue	$69.6 million
Funding	$21 million
Employees	69 (1 on RocketReach)
Founded	2007
Address	Biopark, Broadwater Rd, Welwyn Garden City, Hertfordshire AL7 3AX, GB
Phone	+44 1707 448020
Industry	Business Services, Biotechnology, Drug Discovery, Science and Engineering, Pharmaceutical, Health Care, Therapeutics
Web Rank	19 Million
Keywords	Biopharma, G Protein Coupled Receptors, Structure Based Drug Design, Clinical Stage Biopharma, Precision Medicine, Drug Development, Biotechnology, Pharmaceutical Research, Therapeutics, Biologics, Drug Design, Clinical Trials, Medicinal Chemistry, Molecular Biology, Receptor Research, Protein Science, Pharmaceutical
Competitors	GSK, AstraZeneca, Pfizer, Novartis, Merck & Co., Inc., Sanofi, Boehringer Ingelheim, Johnson & Johnson, Lilly India, Roche +36 more (view full list)
SIC	SIC Code 873 Companies, SIC Code 87 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies